Thomson Reuters/Uni...
Health Care: Health Services
Thoratec Corporation (THOR: NASDAQ)
$32.60 -0.63 | -1.90%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 101.32M | 42.66M | 56.89M | 26.46M |
| Receivables | 82.42M | 71.40M | 66.75M | 67.32M |
| Inventories | 47.10M | 55.69M | 59.79M | 66.94M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 397.06M | 337.26M | 590.07M | 457.87M |
| Property, Plant & Equipment, Gross | 87.77M | 82.35M | 81.46M | 120.24M |
| Accumulated Depreciation & Depletion | 41.87M | 43.42M | 43.38M | 68.39M |
| Property, Plant & Equipment, Net | 45.89M | 38.93M | 38.08M | 51.85M |
| Intangibles | 33.57M | 92.28M | 88.52M | 99.86M |
| Other Non-Current Assets | 27.66M | 21.32M | 26.07M | 37.69M |
| Total Non-Current Assets | 301.31M | 343.72M | 247.68M | 288.69M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 698.36M | 680.99M | 837.74M | 746.56M |
| Accounts Payable | 19.96M | 12.56M | 13.50M | 8.53M |
| Short Term Debt | 4.22M | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 68.69M | 43.23M | 187.02M | 45.71M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 131.93M |
| Deferred Income Taxes | 2.78M | 20.43M | 20.11M | 31.72M |
| Other Non-Current Liabilities | 30.16M | 32.88M | 9.26M | 12.07M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 32.94M | 53.30M | 29.37M | 175.72M |
| Total Liabilities | 101.62M | 96.54M | 216.38M | 221.43M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 596.74M | 584.45M | 621.36M | 525.13M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 577.45M | 578.29M | 606.78M | 557.42M |
| Cumulative Translation Adjustment | -13.93M | -16.37M | -2.36M | -1.32M |
| Retained Earnings | 34.36M | 24.19M | 18.60M | -30.32M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -1.14M | -1.66M | -1.66M | -648.00K |
| Total Capitalization | 596.74M | 584.45M | 621.36M | 657.06M |
| Total Equity | 596.74M | 584.45M | 621.36M | 525.13M |
| Total Liabilities & Stock Equity | 698.36M | 680.99M | 837.74M | 746.56M |
| Total Common Shares Outstanding | 57.61M | 58.37M | 58.57M | 57.04M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 58.56M | 58.78M | 57.67M | 55.91M |
| Diluted Weighted Shares Outstanding | 59.58M | 62.52M | 59.07M | 57.32M |
| Number of Employees | 855 | 773 | 662 | 1258 |
| Number of Part-Time Employees | 79 | 49 | 52 | 0 |
Portfolios with THOR
- Portfolio NameUser Type
- Usermy portfolio
- ContributorStocks Rising On Unusual Vo...
- ContributorMost-Searched Stocks for th...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Health Care Stocks With ...
- UserAberian System, MEDICAL stocks
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Best-Rate...
- UserJust Lookin'
- UserPART 5 JPMorgan 28th Annual...
Latest THOR Headlines from TheStreet
- 4 Stocks Dragging The Health Services Industry Downward 05.03.13 | 01:05 pm
- THOR Makes Notable Cross Below Critical Moving Average 04.18.13 | 11:04 am
- 8 Stocks Climbing Higher on Unusual Volume 11.21.12 | 02:11 pm
- Sunshine Heart: A Promising Treatment for Heart Failure Patients 11.05.12 | 08:11 am
- Analysts' Actions: TXN HAL DFS CELG THOR 10.03.12 | 10:10 am
- Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 11:08 pm
- Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 11:05 pm
- 7 Hot Stocks on Traders' Radars 04.05.12 | 11:04 am
- Analysts' Actions: CSCO, MMM, CIT, AMGN, S 02.09.12 | 09:02 am
- Thoratec Stock Gaps Up On Today's Open (THOR) 02.09.12 | 08:02 am
Press Releases for THOR
- Thoratec Presentation At Bank Of America Merrill Lynch 2013 Health Care Conference To Be Webcast - PR Newswire 05.14.13 | 09:05 am
- Thoratec Schedules First Quarter Conference Call, Webcast - PR Newswire 04.22.13 | 03:04 pm
- Meet Ms. Joe Ann Bivins, The World's Longest-Supported Recipient Of A Single Heart Assist Device - PR Newswire 03.19.13 | 09:03 am
- Thoratec Announces The First Human Use Of HeartMate PHPâ¿¢ - PR Newswire 03.18.13 | 08:03 am
- Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast - PR Newswire 03.11.13 | 04:03 pm
- Thoratec Presentation At Leerink Swann Global Healthcare Conference To Be Webcast - PR Newswire 02.11.13 | 08:02 am
- Thoratec Schedules Fourth Quarter Conference Call, Webcast - PR Newswire 01.28.13 | 09:01 am
- Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II® - PR Newswire 01.07.13 | 08:01 am
- Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast - PR Newswire 01.03.13 | 08:01 am
- Thoratec Announces Approval For HeartMate II® In Japan - PR Newswire 12.11.12 | 08:12 am
Partner Headlines for THOR
- Bull of the Day: Thoratec Corp. (THOR) - Bull of the Day - Zacks 12.07.12 | 01:12 am
- Stocks Hold Modest Gains; Stratasys Breaks Out - Investor's Business Daily 11.21.12 | 01:11 pm
- Thoratec Achieves 52-Week High - Analyst Blog - Zacks 11.05.12 | 06:11 pm
- Heart Failure: 'New Epidemic' Creates New Opportunities For Investors - Seeking Alpha 11.04.12 | 08:11 am
- Abiomed Beats 2Q Ests, Profit Jumps - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Thoratec Corporation (THOR) - Bull of the Day - Zacks 10.10.12 | 01:10 am
- FDA Approves Abiomed's Impella CP - Analyst Blog - NASDAQ 09.11.12 | 11:09 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - Zacks 09.11.12 | 07:09 pm
- 3 Healthcare Stocks With Positive Momentum - Seeking Alpha 09.01.12 | 08:09 am
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
